Oleh Akchurin1,2, Kelly Meza1, Sharmi Biswas1, Michaela Greenbaum1,2, Alexandra P Licona-Freudenstein1,2, Parag Goyal2,3,4, Justin J Choi2,4, Mary E Choi2,5. 1. Division of Pediatric Nephrology, Department of Pediatrics, Weill Cornell Medicine, New York, New York. 2. New York Presbyterian Hospital, New York, New York. 3. Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, New York. 4. Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York. 5. Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York.
Abstract
BACKGROUND: COVID-19 has affected millions of people, and several chronic medical conditions appear to increase the risk of severe COVID-19. However, our understanding of COVID-19 outcomes in patients with CKD remains limited. METHODS: This was a retrospective cohort study of patients with and without CKD consecutively admitted with COVID-19 to three affiliated hospitals in New York City. Pre-COVID-19 CKD diagnoses were identified by billing codes and verified by manual chart review. In-hospital mortality was compared between patients with and without underlying CKD. Logistic regression was used to adjust this analysis for confounders and to identify patient characteristics associated with mortality. RESULTS: We identified 280 patients with CKD, and 4098 patients without CKD hospitalized with COVID-19. The median age of the CKD group was 75 (65-84) years, and age of the non-CKD group 62 (48-75) years. Baseline (pre-COVID-19) serum creatinine in patients with CKD was 1.5 (1.2-2.2) mg/dl. In-hospital mortality was 30% in patients with CKD versus 20% in patients without CKD (P<0.001). The risk of in-hospital death in patients with CKD remained higher than in patients without CKD after adjustment for comorbidities (hypertension, diabetes mellitus, asthma, and chronic obstructive pulmonary disease), adjusted OR 1.4 (95% CI,1.1 to 1.9), P=0.01. When stratified by age, elderly patients with CKD (age >70 years) had higher mortality than their age-matched control patients without CKD. In patients with CKD, factors associated with in-hospital mortality were age (adjusted OR, 1.09 [95% CI, 1.06 to 1.12]), P<0.001, baseline and admission serum phosphorus (adjusted OR, 1.5 [95% CI, 1.03 to 2.1], P=0.03 and 1.4 [95% CI, 1.1 to 1.7], P=0.001), serum creatinine on admission >0.3 mg/dl above the baseline (adjusted OR 2.6 [95% CI, 1.2 to 5.4]P=0.01), and diagnosis of acute on chronic kidney injury during hospitalization (adjusted OR 4.6 [95% CI, 2.3 to 8.9], P<0.001). CONCLUSIONS: CKD is an independent risk factor for COVID-19-associated in-hospital mortality in elderly patients. Acute-on-chronic kidney injury increases the odds of in-hospital mortality in patients with CKD hospitalized with COVID-19.
BACKGROUND: COVID-19 has affected millions of people, and several chronic medical conditions appear to increase the risk of severe COVID-19. However, our understanding of COVID-19 outcomes in patients with CKD remains limited. METHODS: This was a retrospective cohort study of patients with and without CKD consecutively admitted with COVID-19 to three affiliated hospitals in New York City. Pre-COVID-19 CKD diagnoses were identified by billing codes and verified by manual chart review. In-hospital mortality was compared between patients with and without underlying CKD. Logistic regression was used to adjust this analysis for confounders and to identify patient characteristics associated with mortality. RESULTS: We identified 280 patients with CKD, and 4098 patients without CKD hospitalized with COVID-19. The median age of the CKD group was 75 (65-84) years, and age of the non-CKD group 62 (48-75) years. Baseline (pre-COVID-19) serum creatinine in patients with CKD was 1.5 (1.2-2.2) mg/dl. In-hospital mortality was 30% in patients with CKD versus 20% in patients without CKD (P<0.001). The risk of in-hospital death in patients with CKD remained higher than in patients without CKD after adjustment for comorbidities (hypertension, diabetes mellitus, asthma, and chronic obstructive pulmonary disease), adjusted OR 1.4 (95% CI,1.1 to 1.9), P=0.01. When stratified by age, elderly patients with CKD (age >70 years) had higher mortality than their age-matched control patients without CKD. In patients with CKD, factors associated with in-hospital mortality were age (adjusted OR, 1.09 [95% CI, 1.06 to 1.12]), P<0.001, baseline and admission serum phosphorus (adjusted OR, 1.5 [95% CI, 1.03 to 2.1], P=0.03 and 1.4 [95% CI, 1.1 to 1.7], P=0.001), serum creatinine on admission >0.3 mg/dl above the baseline (adjusted OR 2.6 [95% CI, 1.2 to 5.4]P=0.01), and diagnosis of acute on chronic kidney injury during hospitalization (adjusted OR 4.6 [95% CI, 2.3 to 8.9], P<0.001). CONCLUSIONS: CKD is an independent risk factor for COVID-19-associated in-hospital mortality in elderly patients. Acute-on-chronic kidney injury increases the odds of in-hospital mortality in patients with CKD hospitalized with COVID-19.
Authors: John R Lee; Jeffrey Silberzweig; Oleh Akchurin; Mary E Choi; Vesh Srivatana; Jonathan Lin; Frank Liu; Line Malha; Michelle Lubetzky; Darshana M Dadhania; Divya Shankaranarayanan; Daniil Shimonov; Sanjay Neupane; Thalia Salinas; Aarti Bhasin; Elly Varma; Lorenz Leuprecht; Supriya Gerardine; Perola Lamba; Parag Goyal; Eric Caliendo; Victoria Tiase; Rahul Sharma; Joel C Park; Peter A D Steel; Manikkam Suthanthiran; Yiye Zhang Journal: Clin J Am Soc Nephrol Date: 2020-09-18 Impact factor: 10.614
Authors: Mary Hannan; Sajid Ansari; Natalie Meza; Amanda H Anderson; Anand Srivastava; Sushrut Waikar; Jeanne Charleston; Matthew R Weir; Jonathan Taliercio; Edward Horwitz; Milda R Saunders; Katherine Wolfrum; Harold I Feldman; James P Lash; Ana C Ricardo Journal: Clin J Am Soc Nephrol Date: 2020-11-11 Impact factor: 8.237
Authors: Parag Goyal; Justin J Choi; Laura C Pinheiro; Edward J Schenck; Ruijun Chen; Assem Jabri; Michael J Satlin; Thomas R Campion; Musarrat Nahid; Joanna B Ringel; Katherine L Hoffman; Mark N Alshak; Han A Li; Graham T Wehmeyer; Mangala Rajan; Evgeniya Reshetnyak; Nathaniel Hupert; Evelyn M Horn; Fernando J Martinez; Roy M Gulick; Monika M Safford Journal: N Engl J Med Date: 2020-04-17 Impact factor: 176.079
Authors: Yasar Caliskan; Seyedmahdi Pahlavani; Ariel Schnell; Aliza Anwar Memon; Fadee Abu Al Rub; Usama Elewa; Marie Philipneri; Kana Miyata; Thanh-Mai Vo; Amy Mosman; Thomas Groll; John Edwards; Krista L Lentine Journal: Turkish J Nephrol Date: 2022-07
Authors: Mahmoud M Zakaria; Safaa A Derbala; Ayman E Salem; Amgad E El-Agroudy; Fatma M El-Tantawy Journal: Mol Biol Rep Date: 2021-09-01 Impact factor: 2.316
Authors: Sara S Jdiaa; Razan Mansour; Abdallah El Alayli; Archana Gautam; Preston Thomas; Reem A Mustafa Journal: J Nephrol Date: 2022-01-11 Impact factor: 3.902
Authors: Thomas R Campion; Evan T Sholle; Jyotishman Pathak; Stephen B Johnson; John P Leonard; Curtis L Cole Journal: J Am Med Inform Assoc Date: 2022-03-15 Impact factor: 4.497
Authors: Michael Y Henein; Giulia Elena Mandoli; Maria Concetta Pastore; Nicolò Ghionzoli; Fouhad Hasson; Muhammad K Nisar; Mohammed Islam; Francesco Bandera; Massimiliano M Marrocco-Trischitta; Irene Baroni; Alessandro Malagoli; Luca Rossi; Andrea Biagi; Rodolfo Citro; Michele Ciccarelli; Angelo Silverio; Giulia Biagioni; Joseph A Moutiris; Federico Vancheri; Giovanni Mazzola; Giulio Geraci; Liza Thomas; Mikhail Altman; John Pernow; Mona Ahmed; Ciro Santoro; Roberta Esposito; Guillem Casas; Rubén Fernández-Galera; Maribel Gonzalez; Jose Rodriguez Palomares; Ibadete Bytyçi; Frank Lloyd Dini; Paolo Cameli; Federico Franchi; Gani Bajraktari; Luigi Paolo Badano; Matteo Cameli Journal: J Clin Med Date: 2021-12-14 Impact factor: 4.241